Table 2.

Distribution of mutations in codons 12, 13, and 61 in all patients with NRAS mutations and in patients with inv(16)/t(16;16) and inv(3)/t(3;3)


Codon

All NRAS mutations, no. (%)

NRASmut inv(16)/t(16;16), no. (%)

NRASmut inv(3)/t(3;3), no. (%)
12   112 (43.6)   14 (28.0)   4 (36.4)  
13   54 (21.0)   10 (20.0)   1 (9.1)  
61   64 (24.9)   21 (42.0)   6 (54.5)  
Not sequenced   27 (10.5)   5 (10.0)   0 (0.0)  
Total
 
257 (100.0)
 
50 (100.0)
 
11 (100.0)
 

Codon

All NRAS mutations, no. (%)

NRASmut inv(16)/t(16;16), no. (%)

NRASmut inv(3)/t(3;3), no. (%)
12   112 (43.6)   14 (28.0)   4 (36.4)  
13   54 (21.0)   10 (20.0)   1 (9.1)  
61   64 (24.9)   21 (42.0)   6 (54.5)  
Not sequenced   27 (10.5)   5 (10.0)   0 (0.0)  
Total
 
257 (100.0)
 
50 (100.0)
 
11 (100.0)
 

Frequency of involvement of codon 61 in comparison with involvement of codons 12 and 13, P < .001.

Close Modal

or Create an Account

Close Modal
Close Modal